June 2nd 2025
Moderna's mRNA-1283 vaccine gains FDA approval for high-risk groups, following a significant shift in COVID-19 vaccination guidelines by federal health agencies.
Still Rx'ing Antibiotics for Bronchitis and Non–Group A Strep Sore Throat
October 7th 2013This is an opportunity for primary care to help avert a public health catastrophe. Physicians need to take ownership over this issue and demand more time for URI patients-E&M criteria do not capture what is lost when these visits are viewed simply as “Level 2 Office Visit, CPT 99212.”
Non–Cystic Fibrosis Bronchiectasis: Long-term, Low-dose Erythromycin Is Preferred
April 1st 2013Take-home advice for primary physicians . . . restrict long-term maintenance erythromycin therapy to subsets of patients to protect against increases in macrolide-resistant bacteria in the broader community. Details here . . .